Lars Lidgren received his MD in 1971, PhD in 1973, and became Chair of the Department of Orthopedics at Lund University in 1990. He has been one of the pioneers in systemic antibiotic prophylaxis in joint replacement and is the inventor of several new methods treating chronic osteomyelitis, bacterial arthritis, and knee prosthetic infection. Forty years ago, he started hands-on joint replacement courses. He has published extensively on national implant registers and biomaterials. In addition, a recent focus of his research has been cell-recruiting peptides and antibiotic-containing synthetic bone. Dr. Lidgren has authored and co-authored more than 400 publications in the fields of orthopaedics, biomaterials, infectious diseases, and tissue engineering. Dr. Lidgren is an honorary member of several major societies, including AAOS, RCS, EFORT and ICOR. In 1998, he initiated the worldwide Bone and Joint Decade 2000-2010. He is founder of the biotech companies Bone Support and Scandimed.
For more, read about Dr. Wood's recent work in Tissue Engineering Part A:
Sirka A, Raina DB, Isaksson H, Tanner KE, Smailys A, Kumar A, Tarasevicius S, Tägil M, Lidgren L. Calcium Sulphate/Hydroxyapatite Carrier for Bone Formation in the Femoral Neck of Osteoporotic Rats. Tissue Engineering Part A. 2018 June 1.